Sivik Global Healthcare LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sivik Global Healthcare LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$543.48 - $670.97 $87 Million - $107 Million	-160,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $91.8 Million - $109 Million	160,000 New	160,000 $5.79 Million
Q1 2021 May 12, 2021	SELL	$446.73 - $548.2 $8.93 Million - $11 Million	-20,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $4.78 Million - $6.08 Million	10,000 Added 100.0%	20,000 $9.66 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $2.72 Million - $3.29 Million	-5,000 Reduced 33.33%	10,000 $5.6 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $2.47 Million - $3.22 Million	5,000 Added 50.0%	15,000 $9.36 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $3.36 Million - $4.94 Million	-10,000 Reduced 50.0%	10,000 $4.88 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $2.1 Million - $2.9 Million	7,000 Added 53.85%	20,000 $6.26 Million
Q1 2019 May 08, 2019	BUY	$372.08 - $439.57 $1.12 Million - $1.32 Million	3,000 Added 30.0%	13,000 $5.34 Million
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $3.36 Million - $4.03 Million	10,000 New	10,000 $3.74 Million

1,494

83.1M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.